- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Androgen receptor (AR), encoded by the AR gene and also known as nuclear receptor subfamily 3 group C member 4 (NR3C4), is a ligand-regulated transcription factor that mediates cellular responses to androgens such as testosterone and dihydrotestosterone. The receptor is composed of several functional regions including a large N-terminal transactivation domain, a central DNA-binding domain, and a C-terminal ligand-binding domain. Androgen Receptor Antibody N-Terminal (clone RM254) recognizes an epitope within the N-terminal region of AR, allowing detection of androgen receptor proteins that contain the transcriptional activation domain.
The N-terminal domain of androgen receptor plays a critical role in transcriptional regulation because it contains the activation function-1 region responsible for recruitment of transcriptional coactivators and assembly of transcriptional complexes. This region is also the largest and most structurally flexible portion of the receptor, enabling interactions with multiple regulatory proteins involved in androgen-responsive gene expression. Antibodies targeting the N-terminal domain therefore detect AR proteins that retain the transcriptional regulatory portion of the receptor.
Detection of the AR N-terminal region is particularly important in studies of androgen receptor splice variants. In many biological contexts, especially prostate cancer, truncated AR isoforms lacking the C-terminal ligand-binding domain can arise through alternative splicing or structural rearrangements of the AR gene. These truncated receptors often remain transcriptionally active because the N-terminal transactivation domain is preserved. As a result, antibodies directed against the AR N-terminal domain can detect both the full-length receptor and variant AR proteins that lack the C-terminal region.
In contrast, antibodies directed toward the C-terminal ligand-binding domain detect only the full-length androgen receptor. This difference makes N-terminal antibodies especially useful in research examining androgen receptor signaling mechanisms, receptor truncation events, and ligand-independent AR activity. Detection of both intact AR and variant receptors provides valuable information about androgen signaling pathways and receptor biology.
Western blot experiments frequently reveal multiple androgen receptor species when N-terminal antibodies are used. The full-length receptor typically migrates near 110 kDa, while truncated AR variants may appear as lower molecular weight bands depending on the specific splice form present. These variant proteins can remain constitutively active and contribute to androgen signaling even in the absence of ligand binding.
Androgen Receptor Antibody N-Terminal (clone RM254) is a recombinant rabbit monoclonal antibody developed to recognize the N-terminal domain of androgen receptor. By targeting this region, the antibody enables detection of both full-length AR and N-terminal containing AR variant proteins, supporting research focused on androgen receptor signaling, splice variant biology, and molecular mechanisms of androgen-responsive gene regulation.
The stated application concentrations are suggested starting points. Titration of the Androgen Receptor Antibody N-Terminal may be required due to differences in protocols and secondary/substrate sensitivity.
1. A pH6 Citrate buffer or pH9 Tris/EDTA buffer HIER step is recommended for testing of FFPE sections.
A peptide corresponding to the N-terminus of Androgen Receptor was used as the immunogen for this recombinant Androgen Receptor antibody.
Store the Androgen Receptor antibody at -20oC (with glycerol) or aliquot and store at -20oC (without glycerol).
Androgen receptor N-terminal antibody, AR N-terminal domain antibody, NR3C4 N-terminal antibody, Androgen receptor transcription activation domain antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.